Critical national shortage of cefazolin in japan: Management strategies

Hitoshi Honda, Shutaro Murakami, Yasuharu Tokuda, Yasuaki Tagashira, Akane Takamatsu

研究成果: ジャーナルへの寄稿学術論文査読

22 被引用数 (Scopus)

抄録

The shortage of antimicrobials poses a global health threat. In Japan, for instance, the current, critical shortage of cefazolin, a firstline agent for the treatment of common infectious diseases and surgical antimicrobial prophylaxis, has had a substantial impact on inpatient care. A shortage of essential antimicrobial agents like cefazolin leads to increased consumption of alternative antimicrobial agents with broad-spectrum activity, with the unintended consequence of militating against antimicrobial stewardship efforts in inpatient settings and potentially promoting antimicrobial resistance. Although there is global awareness of the shortage of crucial antimicrobials, action to resolve this problem, especially with a view to preventing antimicrobial resistance and promoting antimicrobial stewardship, has been slow, possibly due to the failure to appreciate the urgency of the dilemma. A comprehensive plan for stabilizing antimicrobial access and international collaboration to secure a continuous supply of essential antimicrobials are urgently needed.

本文言語英語
ページ(範囲)1783-1789
ページ数7
ジャーナルClinical Infectious Diseases
71
7
DOI
出版ステータス出版済み - 01-10-2020
外部発表はい

All Science Journal Classification (ASJC) codes

  • 微生物学(医療)
  • 感染症

フィンガープリント

「Critical national shortage of cefazolin in japan: Management strategies」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル